Massive Life Sciences Mergers & Acquisitions To Occur In 2023

mRNA platform, sizable clinical pipeline of cell-gene therapies provide a wealth of prospective acquisition targets in 2023, says M&A Firepower study from E&Y.

5 Challenges That Will Affect Developing Biotech In 2023

This year will present a variety of difficulties for biotech firms and their investors, including slump in public markets, effects of Inflation Reduction Act.

How Technology is Evolving to Help Fight Diseases

Expanding the application of AI to know a disease fully can yield insights for drug development that result in ground-breaking discoveries in drug research.

Update On The Clinical Trials Regulation Implementation

Clinical trial financiers, administrators will employ clinical trial information system, a searchable database for medical staff, participants, and the public.

5 FDA Announcements To Pay Attention To In The 2023 Q1

Among the most crucial choice made by FDA by the end of March are those relating an Alzheimer's drug, a gene therapy for haemophilia, and 2 breast cancer drugs.

Watch Out For These Potential Best-Seller Drugs In 2023

2 possible blockbusters as per 2023 Drugs to WatchTM report are lecanemab for Alzheimes and first potential gene medicine ready for US launch for haemophilia A.